Close

PhaseBio Pharmaceuticals Inc. (PHAS) Plans for Near-Term Sale Using Structured Process Through Chapter 11 of U.S. Bankruptcy Code Oct 24, 2022 08:08AM
PhaseBio Plans for Near-Term Sale Using Structured Process Through Chapter 11 of U.S. Bankruptcy Code Oct 24, 2022 08:00AM
PhaseBio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Business Highlights Aug 12, 2022 08:30AM
PhaseBio Pharmaceuticals Inc. (PHAS) Reports Successful Pre-BLA Meeting with the FDA for Bentracimab May 16, 2022 06:03AM
PhaseBio Announces Successful Pre-BLA Meeting with U.S. FDA for Bentracimab May 16, 2022 06:00AM


May 16, 2022 06:00AM PhaseBio Pharmaceuticals Reports First Quarter 2022 Financial Results and Recent Business Highlights
Apr 7, 2022 04:00PM PhaseBio Pharmaceuticals to Participate in the 21st Annual Needham Healthcare Conference
Apr 4, 2022 08:04AM PhaseBio Pharmaceuticals Inc. (PHAS) Reports Positive Results from Phase 2b Trial for Bentracimab
Apr 4, 2022 08:00AM PhaseBio Announces Positive Results from Phase 2b Trial for Bentracimab
Mar 24, 2022 04:01PM PhaseBio Pharmaceuticals Inc. (PHAS) Reports Q4 Results, Provides Recent Business Highlights
Mar 24, 2022 04:00PM PhaseBio Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlights
Mar 8, 2022 08:01AM PhaseBio Pharmaceuticals Inc. (PHAS) Provides Update on Bentracimab Manufacturing
Mar 8, 2022 08:00AM PhaseBio Pharmaceuticals Announces Bentracimab Manufacturing Update
Feb 24, 2022 04:00PM PhaseBio Pharmaceuticals to Participate in the Cowen 42nd Annual Health Care Conference
Feb 10, 2022 08:03AM PhaseBio Pharmaceuticals Inc. (PHAS) to Present Bentracimab Phase 2b Trial Data
Feb 10, 2022 08:00AM PhaseBio Announces Bentracimab Phase 2b Trial Data Accepted for Late Breaking Clinical Research Presentation at the 2022 American College of Cardiology (ACC.22) Annual Scientific Session
Dec 21, 2021 08:01AM PhaseBio Pharmaceuticals Inc. (PHAS) is voluntarily ending Phase 2b trial of pemziviptadil in PAH due to COVID-19 impacts on manufacturing
Dec 21, 2021 08:00AM PhaseBio Provides Pemziviptadil (PB1046) Program Update
Dec 1, 2021 05:02PM PhaseBio Pharmaceuticals Inc. (PHAS) Reports Publication of Interim Results from Pivotal REVERSE-IT Phase 3 Trial of Bentracimab
Dec 1, 2021 05:01PM PhaseBio Announces Publication of Interim Results from Pivotal REVERSE-IT Phase 3 Trial of Bentracimab in NEJM Evidence
Nov 18, 2021 04:01PM PhaseBio Names Jonathan Birchall as Chief Commercial Officer
Nov 15, 2021 11:32AM PhaseBio (PHAS) Announces Interim Results from Pivotal REVERSE-IT Phase 3 Trial of Bentracimab for Reversal of Antiplatelet Effects of Ticagrelor in Patients Requiring Urgent Surgery or Experiencing
Nov 15, 2021 11:31AM PhaseBio Announces Interim Results from Pivotal REVERSE-IT Phase 3 Trial of Bentracimab for the Reversal of Antiplatelet Effects of Ticagrelor in Patients Requiring Urgent Surgery or Experiencing Unco
Nov 10, 2021 04:00PM PhaseBio Reports Third-Quarter 2021 Financial Results and Recent Business Highlights
Nov 10, 2021 08:01AM PhaseBio Pharmaceuticals to Host Investor Call to Discuss Interim Results from Pivotal REVERSE-IT Phase 3 Trial Presented at the American Heart Association Annual Meeting
Nov 3, 2021 08:08AM PhaseBio Pharmaceuticals Inc. (PHAS) Announces Topline Results From Phase 2b Trial for Bentracimab
Nov 3, 2021 08:00AM PhaseBio Announces Topline Results From Phase 2b Trial for Bentracimab
Oct 6, 2021 08:00AM PhaseBio Announces Interim Analysis of REVERSE-IT Phase 3 Trial Accepted for Late Breaking Science Presentation at the American Heart Association Scientific Sessions 2021
Sep 15, 2021 08:02AM PhaseBio Pharmaceuticals Inc. (PHAS) Appoints William D. Humphries to its Board; Justin Klein Steps Down
Sep 15, 2021 08:00AM PhaseBio Appoints William D. Humphries to Board of Directors
Aug 31, 2021 04:00PM PhaseBio Pharmaceuticals to Present at 23rd Annual H.C. Wainwright Global Investment Conference
Aug 12, 2021 08:30AM PhaseBio Reports Second-Quarter 2021 Financial Results and Recent Business Highlights
Aug 12, 2021 08:00AM PhaseBio Pharmaceuticals Achieves Enrollment Milestones Supporting Interim Analysis of REVERSE-IT Global Phase 3 Trial, Enabling Preparation of a BLA submission for Bentracimab for Reversal of Antipla
Aug 10, 2021 08:02AM PhaseBio Pharmaceuticals (PHAS) and SFJ Pharmaceuticals Announce Approval of IND Application in China for Bentracimab
Aug 10, 2021 08:00AM PhaseBio Pharmaceuticals and SFJ Pharmaceuticals® Announce Approval of IND Application in China for Bentracimab
Jun 30, 2021 04:00PM PhaseBio Pharmaceuticals to Present at the William Blair Biotech Focus Conference 2021 on July 15
Jun 17, 2021 08:06AM PhaseBio (PHAS) Announces European Licensing Agreement with Alfasigma S.p.A for Commercialization of Bentracimab
Jun 17, 2021 08:00AM PhaseBio Announces European Licensing Agreement with Alfasigma S.p.A for Commercialization of Bentracimab
May 20, 2021 04:30PM PhaseBio Highlights Real-World Healthcare Cost and Bleeding Cost Data Featured at the International Society for Pharmacoeconomic and Outcomes Research (ISPOR) Virtual 2021 Conference
May 17, 2021 04:35PM PhaseBio Pharmaceuticals Inc. (PHAS) Real-World Bleeding and Surgery Data Featured at ACC
May 17, 2021 04:30PM PhaseBio Highlights Real-World Bleeding and Surgery Data Featured at The American College of Cardiology's 70th Annual Scientific Session
May 13, 2021 04:00PM PhaseBio Reports First-Quarter 2021 Financial Results and Recent Business Highlights
Apr 7, 2021 04:05PM PhaseBio Pharmaceuticals to Present at 20th Annual Needham Virtual Healthcare Conference
Mar 15, 2021 08:00AM PhaseBio Reports Fourth-Quarter and Full-Year 2020 Financial Results and Recent Business Highlights
Feb 26, 2021 04:05PM PhaseBio Pharmaceuticals to Participate in Upcoming Investor Conferences
Feb 24, 2021 04:15PM  PhaseBio Pharmaceuticals to Host Virtual Investor and Analyst Day on March 15, 2021
Jul 17, 2020 09:29AM Pre-Open Movers 07/17: (APDN) (OCN) (HMHC) Higher; (NIO) (NFLX) (ROKU) Lower (more...)
May 28, 2020 09:03AM Pre-Open Stock Movers 05/28: (PHAS) (TGI) (DLTR) (TOL) (ALXN) (HTZ) (TWTR) (More...)